These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16126125)

  • 1. Hypertension in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2005 Oct; 70(1):71-80. PubMed ID: 16126125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M; Amini M
    Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran.
    Janghorbani M; Amini M; Ghanbari H; Safaiee H
    Ophthalmic Epidemiol; 2003 Apr; 10(2):81-95. PubMed ID: 12660857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of and risk factors for cataract among diabetes clinic attenders.
    Janghorbani MB; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Mar; 7(1):13-25. PubMed ID: 10652168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders.
    Janghorbani M; Jones RB; Murray KJ; Allison SP
    Ophthalmic Epidemiol; 2001 Dec; 8(5):309-25. PubMed ID: 11922384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleeping disturbances and predictor risk factors among type 2 diabetic mellitus patients.
    Bener A; Al-Hamaq AOAA; Agan AF; Öztürk M; Ömer A
    Ann Afr Med; 2020; 19(4):230-236. PubMed ID: 33243945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of and risk factors for proliferative retinopathy and its association with blindness among diabetes clinic attenders.
    Janghorbani M; Jones RB; Allison SP
    Ophthalmic Epidemiol; 2000 Dec; 7(4):225-41. PubMed ID: 11262670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of renal failure in NIDDM. The Oklahoma Indian Diabetes Study.
    Lee ET; Lee VS; Lu M; Lee JS; Russell D; Yeh J
    Diabetes; 1994 Apr; 43(4):572-9. PubMed ID: 8138063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.
    Janghorbani M; Amini M; Tavassoli A
    Acta Cardiol; 2006 Feb; 61(1):13-20. PubMed ID: 16485728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in type 2 diabetes mellitus in isfahan, iran: prevalence and risk factors.
    Janghorbani M; Amini M
    Metab Syndr Relat Disord; 2007 Sep; 5(3):243-54. PubMed ID: 18370778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran.
    Janghorbani M; Amini M
    Endokrynol Pol; 2012; 63(5):372-80. PubMed ID: 23115071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of non-insulin-dependent diabetes mellitus and its risk factors in Japanese-Americans living in Hawaii and Los Angeles.
    Hara H; Egusa G; Yamakido M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S133-42. PubMed ID: 8894497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Time to Development of Hypertension and Its Predictors among a Cohort of Diabetic Patients in Health Facilities of Gurage Zone: A Retrospective Follow-Up Study.
    Migora B; Geleso MG; Girum T; Bireda M; Gebru M; Dessu S
    Vasc Health Risk Manag; 2021; 17():259-266. PubMed ID: 34079273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors.
    Janghorbani M; Aminorroaya A; Amini M
    Int J Hypertens; 2017; 2017():3132729. PubMed ID: 29423321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION AMONG TYPE 2 DIABETIC PATIENTS AT MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
    Ndege BW; Diero LO; Owiti MO; Anjichi G; Siika AM
    East Afr Med J; 2014 Aug; 91(8):253-60. PubMed ID: 26862649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of hypertension among Saudi type 2 diabetes adult patients: an 11-year prospective randomized study.
    Salman RA; Al-Rubeaan KA
    J Diabetes Complications; 2009; 23(2):95-101. PubMed ID: 18413199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.
    Park JY; Kim HK; Chung YE; Kim SW; Hong SK; Lee KU
    Diabetes Care; 1998 Apr; 21(4):530-4. PubMed ID: 9571337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Serum Uric Acid and Incident Hypertension in Patients with Type 2 Diabetes.
    Janghorbani M; Ghanbari H; Aminorroaya A; Amini M
    Rev Diabet Stud; 2018; 14(4):354-363. PubMed ID: 29590228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study.
    Palmieri V; Bella JN; Arnett DK; Liu JE; Oberman A; Schuck MY; Kitzman DW; Hopkins PN; Morgan D; Rao DC; Devereux RB
    Circulation; 2001 Jan; 103(1):102-7. PubMed ID: 11136693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.